(Q40190123)

18 September 2017

1 reference

title

Survey of the human acetylator polymorphism in spontaneous disorders (English)

1 reference

18 September 2017

D A Evans

1

1 reference

PMCID

1049291

18 September 2017

language of work or name

English

0 references

publication date

1 August 1984

1 reference

Journal of Medical Genetics

18 September 2017

1 reference

18 September 2017

21

1 reference

18 September 2017

243-253

1 reference

18 September 2017

4

1 reference

On estimating the relation between blood group and disease

18 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

The estimation and significance of the logarithm of a ratio of frequencies

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Ethanol-induced increase in procainamide acetylation in man.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Hydralazine, antinuclear antibodies, and the lupus syndrome

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

The association of the slow acetylator phenotype with bladder cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

An improved and simplified method of detecting the acetylator phenotype

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

A filter paper method for determining isoniazid acetylator phenotype

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Antinuclear factor in rapid and slow acetylator patients treated with isoniazid

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Polymorphic acetylation of nitrazepam

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Metabolism of sulphadiazine in malnutrition

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

P-aminosalicylate metabolism in cancer patients sensitive and resistant to chemotherapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Acetylator phenotype in spontaneous SLE and rheumatoid arthritis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

The influence of acetylator phenotype on the outcome of treatment with phenelzine, in a clinical trial

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Acetylator phenotype in systemic lupus erythematosus

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Polymorphic acetylation and aminopyrine demethylation in Gilbert's syndrome

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Significance of the acetylation phenotype and the therapeutic effect of procainamide

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Acetylator phenotypes and type I (insulin-dependent) diabetics with microvascular disease.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

The effect of the acetylator phenotype on the metabolism of sulphasalazine in man

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

The acetylation of sulfamethazine and sulfamethoxypyridazine by human subjects

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

The polymorphic acetylation of sulphapyridine in man

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

The use of the autoanalyzer to determine the acetylator phenotype.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Dapsone acetylation in dermatitis herpetiformis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Dapsone Acetylation and the Treatment of Leprosy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Acetylator status and response to phenelzine in depressed patients.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Acetylator phenotype and the antihypertensive response to hydralazine

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Editorial: Criteria for classification of systemic lupus erythematosus

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Acetylator phenotype in patients with hydralazine-induced lupoid syndrome.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Comparison of isoniazid phenotyping of black and white patients with emphasis on South African blacks

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Isoniazid phenotyping of black as well as white patients

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Dihydralazine therapy and acetylator phenotype

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Diabetic dimorphism according to acetylator status

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

ABO blood groups and secretor character in duodenal ulcer; population and sibship studies.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Simplified method for determining acetylator phenotype.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

Determination of acetylator status in uraemia

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1049291

High-performance liquid chromatographic determination of aminosalicylate, sulfapyridine and their metabolites. Its application for pharmacokinetic studies with salicylazosulfapyridine in man

20 August 2018

1 reference

12 December 2020

Hepatic acetylator phenotype in porphyria cutanea tarda

1 reference

12 December 2020

Hepatic acetylator phenotype in diabetes mellitus

1 reference

12 December 2020

Acetylator phenotype in idiopathic systemic lupus erythematosus

1 reference

12 December 2020

Acetylator status and diabetic neuropathy

1 reference

12 December 2020

The acetylator phenotype of patients with systemic lupus erythematosus

1 reference

12 December 2020

Inactivation of drugs by acetylation

1 reference

12 December 2020

Acetylator phenotype, minimal maintenance dose and haemolytic effect of dapsone in dermatitis herpetiformis

1 reference

12 December 2020

The application of urine tests to monitor the regularity of dapsone self-administration

1 reference

12 December 2020

Relation of hydralazine plasma concentration to dosage and hypotensive action

1 reference

12 December 2020

Normal distribution of acetylation phenotypes in systemic lupus erythematosus

1 reference

12 December 2020

Acetylation phenotype in rheumatoid arthritis

1 reference

12 December 2020

Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease

1 reference

12 December 2020

Slow acetylation phenotype in systemic lupus erythematosus

1 reference

12 December 2020

The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine

1 reference

12 December 2020

The Acetylator Phenotypes of Duodenal Ulcer Patients

1 reference

12 December 2020

Dapsone Metabolism in Patients with Dapsone-Resistant Leprosy

1 reference

12 December 2020

Pharmacokinetic observations on dapsone in dermatitis herpetiformis

1 reference

12 December 2020

N-acetylation phenotype in bladder cancer

1 reference

12 December 2020

Induction of acetylating capacity with complete Freund's adjuvant and hydrocortisone in the rabbit

1 reference

12 December 2020

Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function

1 reference

12 December 2020

Lea blood group substance degradation in the human alimentary tract and urinary Lea in coeliac disease

1 reference

12 December 2020

Acetylation pattern of different sulphonamides in rapid and slow isoniazid inactivators

1 reference

12 December 2020

Ethanol-induced increase in drug acetylation in man and isolated rat liver cells

1 reference

12 December 2020

Acetylator phenotype in rheumatoid arthritis

1 reference

12 December 2020

THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE.

1 reference

12 December 2020

Undernourished adults and acetylation phenotype

1 reference

12 December 2020

Determination of the acetylator phenotype using matrix isoniazid

1 reference

12 December 2020

A STUDY OF THE INFLUENCE OF THE ISONIAZID INACTIVATOR PHENOTYPE ON REVERSION IN GENITO-URINARY TUBERCULOSIS

1 reference

12 December 2020

Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver

1 reference

12 December 2020

Acetylator phenotype in diabetic neuropathy

1 reference

12 December 2020

Polymorphic Acetylation of the Antibacterials, Sulfamethazine and Dapsone, in South Indian Subjects *

1 reference

12 December 2020

Acute hepatitis B associated with gynaecological surgery

1 reference

12 December 2020

[Lupus erythematosus disseminatus and active isoniazid levels. A study of 47 cases]

1 reference

12 December 2020

Absorption of ethionamid, isoniazid, and aminosalicylic acid from the post-resection gastrointestinal tract

1 reference

12 December 2020

GENETICAL ASPECT OF ISONIAZID METABOLISM

1 reference

12 December 2020

Acetylator phenotype in patients with breast cancer

1 reference

12 December 2020

Renal clearance of sodium sulphadimidine in normal and uraemic subjects

1 reference

12 December 2020

HUMAN ACETYLATION POLYMORPHISM

1 reference

12 December 2020

Sulfasalazine metabolite pharmacokinetics in pediatric patients with inflammatory bowel disease: effects of disease activity, acetylator phenotype, and age

1 reference

12 December 2020

Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital

1 reference

12 December 2020

Inactivation of isoniazid and sulphadimidine in mongoloid subjects

1 reference

12 December 2020

Spontaneous systemic lupus erythematosus and acelylator phenotype

1 reference

12 December 2020

Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy

1 reference

12 December 2020

Evaluation of the sulphapyridine acetylator phenotyping test in healthy subjects and in patients with cardiac and renal diseases

1 reference

12 December 2020

Cutaneous reactions to drugs, acetylation phenotype and HLA antigens in patients with and without systemic lupus erythematosus (SLE)

1 reference

12 December 2020

Identifiers

PMCID

1049291

1 reference

18 September 2017

1 reference

PMCID

1049291